Suppression of microRNA-142-5p attenuates hypoxia-induced apoptosis through targeting SIRT7

Liying Zhan1, Shaoqing Lei1, Wenlan Li1

  • 1Department of Anesthesia, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.

Insights

Downregulating microRNA-142-5p (miR-142-5p) protects heart cells from hypoxia-induced injury by increasing Sirtuin7 (SIRT7) expression. This miR-142-5p/SIRT7 pathway offers potential therapeutic targets for ischemic heart disease.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cardiovascular Research

Background:

  • MicroRNAs (miRNAs) are key regulators of cellular responses to hypoxia.
  • miR-142-5p is implicated in cellular survival, but its role in hypoxia-induced injury is unclear.
  • Hypoxia-induced injury is a significant factor in cardiovascular diseases.

Purpose of the Study:

  • To investigate the role of miR-142-5p in regulating cell survival during hypoxia.
  • To elucidate the underlying molecular mechanisms of miR-142-5p in hypoxia-induced injury.
  • To identify potential therapeutic targets for mitigating cardiac damage from hypoxia.

Main Methods:

  • Utilized H9C2 cardiomyoblasts and primary cardiomyocytes for experiments.
  • Manipulated miR-142-5p expression levels (overexpression and suppression) under hypoxia.
  • Employed bioinformatics analysis and dual-luciferase reporter assays to identify miR-142-5p targets.
  • Assessed cell viability, apoptosis, and gene expression (SIRT7).

Main Results:

  • Hypoxia significantly repressed miR-142-5p expression.
  • miR-142-5p overexpression exacerbated hypoxia-induced cell injury and apoptosis.
  • miR-142-5p suppression promoted cell viability and reduced apoptosis during hypoxia.
  • Sirtuin7 (SIRT7) was identified as a direct target of miR-142-5p, with inverse expression correlation.
  • SIRT7 overexpression protected cells against hypoxia-induced injury, while SIRT7 silencing abrogated the protective effects of miR-142-5p suppression.

Conclusions:

  • Downregulation of miR-142-5p alleviates hypoxia-induced injury in cardiomyocytes by upregulating SIRT7.
  • The miR-142-5p/SIRT7 axis represents a promising therapeutic target for ischemic heart disease.
  • Understanding this regulatory pathway can lead to novel strategies for treating conditions involving cardiac hypoxia.